What Is Medical EMC — IEC 60601-1-2?
IEC 60601-1-2 is the electromagnetic compatibility collateral standard for medical electrical equipment. It assesses the electromagnetic interference the device emits and its immunity to external electromagnetic events. The distinguishing point for medical devices is that during immunity testing, the device is required not merely to avoid damage but to maintain its ESSENTIAL PERFORMANCE.
Purpose of Medical EMC — IEC 60601-1-2
The purpose is to assure the device does not suffer a loss of function that would put the patient at risk under the electromagnetic events of its intended environment. What constitutes essential performance is defined by the manufacturer's risk analysis.
Which Products Is Medical EMC — IEC 60601-1-2 Applied To?
- Patient monitors and infusion pumps
- Ventilators and anaesthesia equipment
- Imaging and diagnostic equipment
- Medical devices for home use
- Wirelessly connected medical devices
In Which Sectors Is Medical EMC — IEC 60601-1-2 Used?
Standards Related to Medical EMC — IEC 60601-1-2
- IEC 60601-1-2electromagnetic compatibility in medical electrical devices test
Medical EMC — IEC 60601-1-2 Conditions
- Environment class
- Professional healthcare facility or home healthcare environment; levels vary by environment
- Emissions
- Conducted and radiated emissions per CISPR 11
- Immunity
- ESD, radiated RF field, fast transients, surge, conducted RF, voltage dips and magnetic field
- Essential performance
- Defined by the manufacturer and continuously monitored during testing
Equipment for Medical EMC — IEC 60601-1-2
- Semi-anechoic chamber and antenna set
- EMI receiver and LISN
- ESD simulator, EFT/burst and surge generators
- RF power amplifiers and field generators
- Device function monitoring and simulator rigs
Sample Requirements for Medical EMC — IEC 60601-1-2
- The device must be supplied in its series-production configuration, with all cables and accessories.
- The essential performance definition and monitoring method must be provided in writing by the manufacturer.
- Simulators that run the device as in real use must be provided for testing.
- Cable types and lengths must match those declared.
- The software version must be recorded.
Duration of Medical EMC — IEC 60601-1-2
A full-scope EMC study usually requires several weeks of laboratory time. Monitoring each functional state separately during immunity tests increases the duration.
Medical EMC — IEC 60601-1-2 Procedure
- 1The device's use environment and essential performance are defined.
- 2The test plan and monitoring method are determined.
- 3Emissions measurements are performed.
- 4Immunity tests are applied in sequence.
- 5Essential performance is continuously monitored during each test.
- 6Deviations and self-recovering interruptions are recorded.
- 7Results are assessed together with the risk analysis and reported.
Medical EMC — IEC 60601-1-2 Acceptance Criteria
The acceptance criterion is selected from the relevant section of the standard according to the device's contact type (surface, externally communicating, implant), contact duration and intended use. The assessment relies not on a single test result but on the biological evaluation plan carried out under ISO 10993-1; this page therefore gives no fixed limit.
Evaluation of Results
The assessment relies on emissions staying below the limits and essential performance being preserved during immunity testing. If a loss of essential performance is observed, its risk to the patient is assessed under ISO 14971; an unacceptable risk requires a design change.
Medical EMC — IEC 60601-1-2 Report
- Device identification, model and lot number, if any
- Device contact type, duration and intended use
- Standard and section applied
- Extraction or sample preparation conditions
- Cell line, test system or test rig used
- Controls and their results
- Observations, measurement results and assessment
- A statement that the result applies only to the specimen submitted for testing
Accreditation
EUROLAB holds internationally recognised accreditation obtained from accreditation bodies party to the IAF and ILAC multilateral recognition arrangements, under ISO/IEC 17025 for laboratory testing, ISO/IEC 17020 for inspection and surveillance, and ISO/IEC 17021-1 and ISO/IEC 17065 for system and product certification. This chain ensures the reports and certificates issued are accepted worldwide.
Whether this test can be offered within accredited scope depends on your product and the standard applied; since accreditation is method-based, the scope is confirmed in writing at the quotation stage.
Scope and authorisationsRelated Regulations
- EU 2017/745 Medical Device Regulation (MDR)
- Medical Device Regulation (Türkiye)
- ISO 14971 (risk management for medical devices)
- ISO 13485 (medical devices — quality management system)
Medikal Cihaz Testleri — What Does This Testing Field Cover?
The section below describes the field that the Medical EMC test belongs to; the conditions and acceptance criteria of this particular test are given in the sections above. The scope specific to your product is confirmed in writing at the quotation stage.
Medical device testing shows that a device is safe for the patient and the user and maintains its intended performance. In this family safety is not only about avoiding harm; a device failing to perform its expected function is also treated as a risk. A monitor missing an alarm or a pump delivering the wrong dose is directly a patient safety event.
At the centre of the field is RISK MANAGEMENT, and this is what sets medical apart from other sectors. The risk management process run under ISO 14971 also determines which tests are required. The test list is not copied from a table of standards; it is derived and justified from the device's intended use, the nature and duration of patient contact, the use environment and foreseeable misuse.
Assessment consists of several separate bodies of work, each with its own set of standards. Biocompatibility runs through the ISO 10993 series, electrical device safety through the IEC 60601 series, sterilisation through ISO 11135/11137/17665, packaging through ISO 11607, software through IEC 62304 and usability through IEC 62366. The quality system (ISO 13485) is the framework that binds these together.
Which tests are required is determined by the device's CLASS and its MODE OF CONTACT WITH THE BODY. A product in brief contact with skin and an implant entering the bloodstream do not go through the same test set; the scope is set by a biological evaluation plan prepared under ISO 10993-1. That plan justifies in writing which endpoints are required and why the others are not.
Packaging and sterilisation are taken as seriously as the device itself in this field. For a sterile device the packaging is not a transport container but the barrier that maintains sterility; if the barrier is breached, the device is no longer sterile. Packaging processes are therefore validated and shelf life is supported by real-time ageing data.
For devices containing software, assessment shifts from testing towards PROCESS assurance. IEC 62304 defines which development and verification steps must be followed according to the safety class of the software; the evidence is the traceability of the development process. Testing software does not make it safe — the process record does.
The clinical side is a separate column of the technical file. Test reports show that the device is technically safe; clinical evaluation establishes that the device delivers the intended clinical benefit and that the benefit-risk balance is acceptable. Neither replaces the other.
Method groups in this field
Biocompatibility
Cytotoxicity, irritation, skin sensitisation, systemic toxicity, haemocompatibility, genotoxicity and local effects after implantation. The required endpoints are set by the ISO 10993-1 plan.
Electrical device safety
IEC 60601-1 basic safety and essential performance; EMC, alarm, usability and environmental requirements through the collateral standards.
Sterilisation validation
Validation of sterilisation processes by ethylene oxide, radiation or moist heat; bioburden and sterility assurance level studies.
Packaging
Integrity of the sterile barrier system, seal strength, distribution simulation and shelf-life studies.
Microbiological tests
Bioburden determination, sterility testing, bacterial endotoxin and, where required, carrier validation studies.
Software and usability
IEC 62304 life cycle evidence and use-error focused evaluation under IEC 62366.
Commonly confused in this field
- Cytotoxicity alone is not evidence of biocompatibility; the required set of endpoints is determined and justified according to ISO 10993-1.
- An ISO 13485 certificate does not confer CE marking; classification under the MDR, the technical file and the notified body process run separately.
- Accelerated ageing does not replace real-time ageing; a shelf life claim is supported by real-time data.
- A change of material (supplier, pigment, sterilisation method) may require the biological evaluation to be repeated; it is not a silent change.
- An assessment made without the collateral and particular standards for IEC 60601-1 is incomplete; which -1-x and -2-x standards were applied must appear in the report.
- In vitro diagnostic devices fall under the IVDR rather than the MDR, and laboratory equipment is often on the IEC 61010-1 side.
Which decisions these results support
- MDR/IVDR technical file and notified body assessment
- Completing the biological evaluation plan
- Sterilisation and packaging validation
- Determining shelf life and storage conditions
- Determining the scope of reassessment after a design change
Related Tests
Frequently Asked Questions About Medical EMC — IEC 60601-1-2
Who defines essential performance?
The manufacturer. The standard requires the manufacturer to define the functions whose loss would create unacceptable risk and to monitor them during testing.
Is there a difference between the home and hospital environment?
Yes. Immunity levels are higher for the home healthcare environment, because the device may be used in an uncontrolled electromagnetic environment without supervision.










